ES2051688T3 - Produccion de inhibidores de trombina. - Google Patents
Produccion de inhibidores de trombina.Info
- Publication number
- ES2051688T3 ES2051688T3 ES86117098T ES86117098T ES2051688T3 ES 2051688 T3 ES2051688 T3 ES 2051688T3 ES 86117098 T ES86117098 T ES 86117098T ES 86117098 T ES86117098 T ES 86117098T ES 2051688 T3 ES2051688 T3 ES 2051688T3
- Authority
- ES
- Spain
- Prior art keywords
- production
- thrombin inhibitors
- eukaryotic host
- hybrid vectors
- desulphatohirudin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/815—Protease inhibitors from leeches, e.g. hirudin, eglin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE PROPORCIONA UN METODO PARA LA PRODUCCION Y SECRECCION DE PROTEINAS CON ACTIVIDAD HIRUDINICA EN UNA CELULA EUCARIOTICA HUESPED. TAMBIEN SE PROPORCIONAN VECTORES HIBRIDOS QUE COMPRENDEN UNA SECUENCIA DE DNA QUE INCLUYE UN PEPTIDO SEÑAL INICIAL Y UNA ZONA TRADUCIBLE CON EL GEN ESTRUCTURAL PARA DESULFATO HIRUDINA, Y LAS CELULAS EUCARIOTICAS HUESPEDES TRANSFORMADAS CON DICHOS VECTORES HIBRIDOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858530631A GB8530631D0 (en) | 1985-12-12 | 1985-12-12 | Thrombin inhibitors |
GB868613088A GB8613088D0 (en) | 1985-12-12 | 1986-05-29 | Thrombin inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2051688T3 true ES2051688T3 (es) | 1994-07-01 |
Family
ID=26290108
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES86117098T Expired - Lifetime ES2051688T3 (es) | 1985-12-12 | 1986-12-09 | Produccion de inhibidores de trombina. |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP0225633B1 (es) |
JP (2) | JPH0650990B2 (es) |
AT (1) | ATE79403T1 (es) |
AU (1) | AU615413B2 (es) |
CA (1) | CA1341496C (es) |
DE (1) | DE3686399T2 (es) |
DK (1) | DK175492B1 (es) |
ES (1) | ES2051688T3 (es) |
FI (1) | FI94773C (es) |
GR (1) | GR3006248T3 (es) |
HU (1) | HU209146B (es) |
IE (1) | IE57859B1 (es) |
IL (1) | IL80932A (es) |
MY (1) | MY101203A (es) |
NO (1) | NO178035C (es) |
PH (1) | PH31277A (es) |
PT (1) | PT83898B (es) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3583361D1 (de) * | 1984-06-14 | 1991-08-08 | Ucp Gen Pharma Ag | Verfahren zur herstellung von thrombin-inhibitoren. |
MC1834A1 (fr) * | 1986-07-10 | 1988-06-03 | Transgene Sa | Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation |
GB8620926D0 (en) * | 1986-08-29 | 1986-10-08 | Delta Biotechnology Ltd | Yeast promoter |
CA1341032C (en) * | 1987-01-23 | 2000-06-20 | John L. Krstenansky | Anticoagulant peptides |
US5789540A (en) * | 1987-01-23 | 1998-08-04 | Merrell Pharmaceuticals Inc. | Anticoagulant peptides |
US6005071A (en) * | 1987-01-23 | 1999-12-21 | Merrell Pharmaceuticals Inc. | Anticoagulant peptides |
US5256559A (en) * | 1988-03-04 | 1993-10-26 | Biogen, Inc. | Methods and compositions for inhibiting platelet aggregation |
GB8809860D0 (en) * | 1988-04-26 | 1988-06-02 | Ciba Geigy Ag | Process for production of polypeptides |
GB8907110D0 (en) * | 1988-05-04 | 1989-05-10 | Ciba Geigy Ag | Improvements in the production of polypeptides |
US5268296A (en) * | 1988-06-11 | 1993-12-07 | Ciba-Geigy Corporation | DNA vector and recombinant host cell for production of hirullin P6 and P18 |
US5167960A (en) * | 1988-08-03 | 1992-12-01 | New England Deaconess Hospital Corporation | Hirudin-coated biocompatible substance |
US5112615A (en) * | 1988-08-03 | 1992-05-12 | New England Deaconess Hospital Corporation | Soluble hirudin conjugates |
GB8826428D0 (en) * | 1988-11-11 | 1988-12-14 | Biopharm Ltd | Antithrombin |
FR2646437B1 (fr) * | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
US5179196A (en) * | 1989-05-04 | 1993-01-12 | Sri International | Purification of proteins employing ctap-iii fusions |
DE4009268A1 (de) * | 1990-03-22 | 1991-09-26 | Consortium Elektrochem Ind | Sekretion von hirudinderivaten |
US6514730B1 (en) | 1991-03-21 | 2003-02-04 | Consortium für elektrochemische Industrie GmbH | Secretion of hirudin derivatives |
PT592358E (pt) * | 1992-09-04 | 2001-03-30 | Ucp Gen Pharma Ag | Processo para a producao de inibidores de proteases |
AU707657B2 (en) | 1995-02-09 | 1999-07-15 | Behringwerke Aktiengesellschaft | Process for the production of proteins |
US7795205B2 (en) | 2004-04-12 | 2010-09-14 | Canyon Pharmaceuticals, Inc. | Methods for effecting regression of tumor mass and size in a metastasized pancreatic tumor |
JP7284955B2 (ja) * | 2020-07-20 | 2023-06-01 | フォーデイズ株式会社 | 神経幹細胞の増殖促進剤及びそれを用いた神経幹細胞の増殖促進方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1984004330A1 (en) * | 1983-04-22 | 1984-11-08 | Amgen | Secretion of exogenous polypeptides from yeast |
EP0656418B1 (en) * | 1983-10-03 | 2002-12-04 | Chiron Corporation | Superoxide dismutase and expression in microorganisms |
EP0143081B1 (en) * | 1983-11-21 | 1989-08-23 | Ciba-Geigy Ag | Synthesis of tissue plasminogen activator(tpa) by yeast |
DE3342139A1 (de) * | 1983-11-22 | 1985-05-30 | Ciba-Geigy Ag, Basel | Desulfatohirudine, verfahren zu ihrer herstellung und pharmazeutische mittel |
DE3586333T2 (de) * | 1984-03-27 | 1992-12-10 | Transgene Sa | Expressionsvektoren fuer hirudin, transformierte zellen und verfahren zur herstellung von hirudin. |
DE3583361D1 (de) * | 1984-06-14 | 1991-08-08 | Ucp Gen Pharma Ag | Verfahren zur herstellung von thrombin-inhibitoren. |
FR2568891B1 (fr) * | 1984-08-09 | 1988-05-27 | Transgene Sa | Procede de preparation d'une souche, notamment de levure, transformee par un vecteur d'expression, qui peut etre cultivee sur un milieu complet sans pression de selection et souche ainsi obtenue |
DE3429430A1 (de) * | 1984-08-10 | 1986-02-20 | Hoechst Ag, 6230 Frankfurt | Gentechnologisches verfahren zur herstellung von hirudin und mittel zur durchfuehrung dieses verfahrens |
FR2593518B1 (fr) * | 1985-05-02 | 1989-09-08 | Transgene Sa | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
GB8521496D0 (en) * | 1985-08-29 | 1985-10-02 | Ciba Geigy Ag | Repressible yeast promoters |
MC1834A1 (fr) * | 1986-07-10 | 1988-06-03 | Transgene Sa | Bloc fonctionnel d'adn et plasmide codant pour l'hirudine,levure transformee,procede de preparation de l'hirudine,hirudine obtenue et son utilisation |
-
1986
- 1986-12-04 MY MYPI86000173A patent/MY101203A/en unknown
- 1986-12-08 FI FI865003A patent/FI94773C/fi not_active IP Right Cessation
- 1986-12-09 ES ES86117098T patent/ES2051688T3/es not_active Expired - Lifetime
- 1986-12-09 DE DE8686117098T patent/DE3686399T2/de not_active Expired - Lifetime
- 1986-12-09 AT AT86117098T patent/ATE79403T1/de not_active IP Right Cessation
- 1986-12-09 EP EP86117098A patent/EP0225633B1/en not_active Expired - Lifetime
- 1986-12-10 CA CA000524903A patent/CA1341496C/en not_active Expired - Fee Related
- 1986-12-10 IL IL80932A patent/IL80932A/en not_active IP Right Cessation
- 1986-12-10 PT PT83898A patent/PT83898B/pt unknown
- 1986-12-11 IE IE3244/86A patent/IE57859B1/en not_active IP Right Cessation
- 1986-12-11 AU AU66504/86A patent/AU615413B2/en not_active Expired
- 1986-12-11 JP JP61293558A patent/JPH0650990B2/ja not_active Expired - Lifetime
- 1986-12-11 NO NO865007A patent/NO178035C/no not_active IP Right Cessation
- 1986-12-11 HU HU865177A patent/HU209146B/hu unknown
- 1986-12-11 DK DK198605952A patent/DK175492B1/da not_active IP Right Cessation
-
1988
- 1988-04-07 PH PH36763A patent/PH31277A/en unknown
-
1992
- 1992-11-13 GR GR920401771T patent/GR3006248T3/el unknown
-
1993
- 1993-11-12 JP JP5282983A patent/JPH0787791B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
PH31277A (en) | 1998-07-06 |
PT83898B (pt) | 1989-06-30 |
FI94773C (fi) | 1995-10-25 |
DK595286D0 (da) | 1986-12-11 |
IL80932A0 (en) | 1987-03-31 |
DK175492B1 (da) | 2004-11-08 |
HUT42523A (en) | 1987-07-28 |
EP0225633A2 (en) | 1987-06-16 |
FI865003A0 (fi) | 1986-12-08 |
JPS62208296A (ja) | 1987-09-12 |
IL80932A (en) | 1998-02-22 |
IE863244L (en) | 1987-06-12 |
NO865007D0 (no) | 1986-12-11 |
JPH0787791B2 (ja) | 1995-09-27 |
NO178035B (no) | 1995-10-02 |
HU209146B (en) | 1994-03-28 |
FI94773B (fi) | 1995-07-14 |
DE3686399T2 (de) | 1993-01-14 |
JPH0650990B2 (ja) | 1994-07-06 |
JPH06197766A (ja) | 1994-07-19 |
NO178035C (no) | 1996-01-10 |
DK595286A (da) | 1987-06-13 |
ATE79403T1 (de) | 1992-08-15 |
DE3686399D1 (de) | 1992-09-17 |
GR3006248T3 (es) | 1993-06-21 |
MY101203A (en) | 1991-08-17 |
NO865007L (no) | 1987-06-15 |
CA1341496C (en) | 2006-02-14 |
IE57859B1 (en) | 1993-04-21 |
AU615413B2 (en) | 1991-10-03 |
EP0225633A3 (en) | 1988-11-30 |
PT83898A (en) | 1987-01-01 |
AU6650486A (en) | 1987-06-18 |
EP0225633B1 (en) | 1992-08-12 |
FI865003A (fi) | 1987-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2051688T3 (es) | Produccion de inhibidores de trombina. | |
DE69127829D1 (de) | Expression von pace in wirtszellen und verfahren zu dessen verwendung | |
PT88479A (pt) | Metodo para cultura de celulas recombinantes | |
DE68927344D1 (de) | Hefezellen der Gattung-Schwanniomyces | |
IL68366A (en) | Process for expressing a gene encoding a protein comprising the enzymatic portion of human urokinase in a microorganism or cell culture | |
DE3786592D1 (de) | Transformation von trichoderma. | |
IL87255A0 (en) | Dna constructs containing a kluyveromyces alphafactor leader sequence for directing secretion of heterologous polypeptides | |
FI90667C (fi) | Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia | |
DK509886A (da) | Udtrykkelsesforoegende dna-sekvenser | |
LV10494A (lv) | Panemiens savienotu olbaltumvielu gena strukturas hibrida iegusanai un streptomicetu transformesanas panemiens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 225633 Country of ref document: ES |